Under a
not-for-profit pilot program, drug company
Pharmacia has agreed to transfer its proprietary manufacturing technology and regulatory dossier for
delavirdine, a medicine for
HIV/AIDS, to
IDA [The International Dispensary Association]
IDA, in turn, will be
empowered to select any generic companies that meet its quality manufacturing standards. As the
world's largest non-profit supplier of generic medicines to developing countries and relief agencies, IDA is uniquely positioned to facilitate manufacturing and supply of generic delavirdine in eligible countries.
See
Medecins Sans Frontieres' Access to Essential Medicines website to find out why this and other similar schemes are needed in order to help fight
Malaria, TB + AIDS (plus other
preventable killer diseases) in many of the world's poorest nations and the
UNAIDS +
AIDS Map websites for more details on the
global AIDS epidemic.
![[Powered by Blogger]](http://buttons.blogger.com/bloggerbutton1.gif){kind=small}
